These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18498876)

  • 61. Regulation of breast cancer response to chemotherapy by fibulin-1.
    Pupa SM; Giuffré S; Castiglioni F; Bertola L; Cantú M; Bongarzone I; Baldassari P; Mortarini R; Argraves WS; Anichini A; Menard S; Tagliabue E
    Cancer Res; 2007 May; 67(9):4271-7. PubMed ID: 17483339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype.
    Libertini SJ; Robinson BS; Dhillon NK; Glick D; George M; Dandekar S; Gregg JP; Sawai E; Mudryj M
    Cancer Res; 2005 Dec; 65(23):10700-8. PubMed ID: 16322214
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand-dependent transformed phenotype.
    Frittitta L; Vigneri R; Stampfer MR; Goldfine ID
    J Cell Biochem; 1995 Apr; 57(4):666-9. PubMed ID: 7615651
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Inactivation and sensitization of the tumor cells by the gene Bax transfection].
    Rodina AV; Sladkova LV; Obukhova VV; Vezirkhanova TZ; Moskaleva EIu; Prusakova OV; Beletskiĭ IP; Belushkina NN; Strel'nikov VV; Ivanov MA; Severin SE; Severin ES
    Mol Biol (Mosk); 2005; 39(1):40-7. PubMed ID: 15773546
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influences of cyclooxygenase-1 and -2 expression on the radiosensitivities of human cervical cancer cell lines.
    Jeon YT; Song YC; Kim SH; Wu HG; Kim IH; Park IA; Kim JW; Park NH; Kang SB; Lee HP; Song YS
    Cancer Lett; 2007 Oct; 256(1):33-8. PubMed ID: 17601662
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human NADPH-cytochrome p450 reductase overexpression does not enhance the aerobic cytotoxicity of doxorubicin in human breast cancer cell lines.
    Ramji S; Lee C; Inaba T; Patterson AV; Riddick DS
    Cancer Res; 2003 Oct; 63(20):6914-9. PubMed ID: 14583491
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Forced COX-2 expression induces PGE(2) and invasion in immortalized urothelial cells.
    Gee J; Lee IL; Grossman HB; Sabichi AL
    Urol Oncol; 2008; 26(6):641-5. PubMed ID: 18367112
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Beta catenin is associated with breast cancer progression in vitro.
    Calaf GM; Alvarado ME; Hei TK
    Int J Oncol; 2005 Apr; 26(4):913-21. PubMed ID: 15753985
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance.
    de Luca A; Moroni N; Serafino A; Primavera A; Pastore A; Pedersen JZ; Petruzzelli R; Farrace MG; Pierimarchi P; Moroni G; Federici G; Sinibaldi Vallebona P; Lo Bello M
    Biochem J; 2011 Dec; 440(2):175-83. PubMed ID: 21834791
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin.
    Narang VS; Pauletti GM; Gout PW; Buckley DJ; Buckley AR
    Chemotherapy; 2007; 53(3):210-7. PubMed ID: 17356269
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells.
    Kim D; Pemberton H; Stratford AL; Buelaert K; Watkinson JC; Lopes V; Franklyn JA; McCabe CJ
    Oncogene; 2005 Jul; 24(30):4861-6. PubMed ID: 15897900
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diminished tumorigenic phenotype after depletion of mitochondrial DNA.
    Cavalli LR; Varella-Garcia M; Liang BC
    Cell Growth Differ; 1997 Nov; 8(11):1189-98. PubMed ID: 9372242
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
    Hyung W; Ko H; Park J; Lim E; Park SB; Park YJ; Yoon HG; Suh JS; Haam S; Huh YM
    Biotechnol Bioeng; 2008 Feb; 99(2):442-54. PubMed ID: 17625788
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin.
    Cheung RY; Rauth AM; Ronaldson PT; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2006 Apr; 62(3):321-31. PubMed ID: 16330194
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Supplementation with l-carnitine does not reduce the efficacy of epirubicin treatment in breast cancer cells.
    Delaney CE; Hopkins SP; Addison CL
    Cancer Lett; 2007 Jul; 252(2):195-207. PubMed ID: 17275999
    [TBL] [Abstract][Full Text] [Related]  

  • 76. COX-2 involvement in breast cancer metastasis to bone.
    Singh B; Berry JA; Shoher A; Ayers GD; Wei C; Lucci A
    Oncogene; 2007 May; 26(26):3789-96. PubMed ID: 17213821
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cell cycle inhibitor, p19INK4d, promotes cell survival and decreases chromosomal aberrations after genotoxic insult due to enhanced DNA repair.
    Scassa ME; Marazita MC; Ceruti JM; Carcagno AL; Sirkin PF; González-Cid M; Pignataro OP; Cánepa ET
    DNA Repair (Amst); 2007 May; 6(5):626-38. PubMed ID: 17218167
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The stability of breast cancer progenitor cells during cryopreservation: Maintenance of proliferation, self-renewal, and senescence characteristics.
    Karimi-Busheri F; Zadorozhny V; Shawler DL; Fakhrai H
    Cryobiology; 2010 Jun; 60(3):308-14. PubMed ID: 20178779
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Truncated RAR beta isoform enhances proliferation and retinoid resistance.
    Swift ME; Wallden B; Wayner EA; Swisshelm K
    J Cell Physiol; 2006 Dec; 209(3):718-25. PubMed ID: 17001699
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ability to acquire drug resistance arises early during the tumorigenesis process.
    Yagüe E; Arance A; Kubitza L; O'Hare M; Jat P; Ogilvie CM; Hart IR; Higgins CF; Raguz S
    Cancer Res; 2007 Feb; 67(3):1130-7. PubMed ID: 17283147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.